Surface Oncology was created to advance next-generation approaches to cancer immunotherapy based on proprietary insights about novel immunotherapy targets and emerging areas of cancer immuno-biology. Together with world-leading scientific founders, the Company is advancing multiple preclinical programs that target novel mechanisms shown to play vital roles in tumor immune evasion.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Surface Oncology Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Surface Oncology Inc market cap is $65.08M.
What is the 52-week high for Surface Oncology Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Surface Oncology Inc 52 week high is $1.43 as of September 16, 2025.
What is the 52-week low for Surface Oncology Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Surface Oncology Inc 52 week low is $0.555 as of September 16, 2025.
What is Surface Oncology Inc stock price today?
Surface Oncology Inc stock price today is $1.07.
What was Surface Oncology Inc stock price yesterday?
Surface Oncology Inc stock price yesterday was $1.08.
What is the PE ratio of Surface Oncology Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Surface Oncology Inc’s P/E ratio is -0.70.
What is the Price-to-Book ratio of Surface Oncology Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Surface Oncology Inc P/B ratio is 1.3213.
What is Surface Oncology Inc's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Surface Oncology Inc's EBITDA is -0.07.
What is the 50-day moving average of Surface Oncology Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Surface Oncology Inc 50-day moving average is $0.9807.